Predictive-modifying therapy in patients with coronary artery disease (IHD): how to optimize treatment?

Diaphragmatic hernia: mechanisms of formation, clinic, treatment tactics

Experience of using pantoprazole in the complex therapy of diseases of the digestive tract of different age groups

Experience of using pantoprazole (Ulsepan) and a combined synbiotic (Opefera) in the complex therapy of children with gastroesophageal reflux disease and gastroduodenitis

Modern approaches to the treatment and prevention of gastrointestinal bleeding associated with NSAID gastropathy and stress ulcers

Ulsepan (pantoprazole) as an effective means of preventing erosive and ulcerative lesions of the gastroduodenal zone in patients during surgical interventions on the organs of the gastrointestinal tract

Drug prevention and treatment of gastropathies associated with the use of non-steroidal anti-inflammatory drugs

Selecting the Optimal Proton Pump Inhibitor for Patients with Coronary Artery Disease Who Require Dual Antiplatelet Therapy

Results of a multicenter study of the effectiveness of Helicobacter pylori eradication, carried out in accordance with the recommendations of the Maastricht Consensus V

The use of pantoprazole in the prevention of NSAID gastropathy

ULSEPAN: pantoprazol 40 mg